Back to Search
Start Over
Combination of Ras Modulator and Azacitidine Impacts Innate Immune Signaling Pathway in MDS-L Cell Line
- Source :
- Blood; November 2021, Vol. 138 Issue: Supplement 1 p4325-4325, 1p
- Publication Year :
- 2021
-
Abstract
- Navada: Janssen Pharmaceuticals, Inc.: Current Employment. Reddy: Onconova Therapeutics, Inc.: Current equity holder in publicly-traded company.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 138
- Issue :
- Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs58317610
- Full Text :
- https://doi.org/10.1182/blood-2021-152764